WO2001083480A3 - Dihydropyridine compounds and methods of use - Google Patents

Dihydropyridine compounds and methods of use Download PDF

Info

Publication number
WO2001083480A3
WO2001083480A3 PCT/US2001/014164 US0114164W WO0183480A3 WO 2001083480 A3 WO2001083480 A3 WO 2001083480A3 US 0114164 W US0114164 W US 0114164W WO 0183480 A3 WO0183480 A3 WO 0183480A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
dihydropyridine compounds
compounds
opening
potassium channel
Prior art date
Application number
PCT/US2001/014164
Other languages
French (fr)
Other versions
WO2001083480A2 (en
Inventor
William A Carroll
Konstantinos A Agrios
Fatima Z Basha
Yiyuan Chen
Michael E Kort
Philip R Kym
Rui Tang
Sean C Turner
Lin Yi
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Priority to CA002407317A priority Critical patent/CA2407317A1/en
Priority to EP01934990A priority patent/EP1278746A2/en
Priority to MXPA02010807A priority patent/MXPA02010807A/en
Priority to JP2001580908A priority patent/JP2004509840A/en
Publication of WO2001083480A2 publication Critical patent/WO2001083480A2/en
Publication of WO2001083480A3 publication Critical patent/WO2001083480A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/44—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by —CHO groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/298—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Compounds having the formula (I) are useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.
PCT/US2001/014164 2000-05-02 2001-05-02 Dihydropyridine compounds and methods of use WO2001083480A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002407317A CA2407317A1 (en) 2000-05-02 2001-05-02 Dihydropyridine compounds and methods of use
EP01934990A EP1278746A2 (en) 2000-05-02 2001-05-02 Dihydropyridine compounds and methods of use
MXPA02010807A MXPA02010807A (en) 2000-05-02 2001-05-02 Dihydropyridine compounds and methods of use.
JP2001580908A JP2004509840A (en) 2000-05-02 2001-05-02 Dihydropyridine compounds and methods of use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56371100A 2000-05-02 2000-05-02
US09/563,711 2000-05-02

Publications (2)

Publication Number Publication Date
WO2001083480A2 WO2001083480A2 (en) 2001-11-08
WO2001083480A3 true WO2001083480A3 (en) 2002-07-18

Family

ID=24251585

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/014164 WO2001083480A2 (en) 2000-05-02 2001-05-02 Dihydropyridine compounds and methods of use

Country Status (5)

Country Link
EP (1) EP1278746A2 (en)
JP (1) JP2004509840A (en)
CA (1) CA2407317A1 (en)
MX (1) MXPA02010807A (en)
WO (1) WO2001083480A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0539154A1 (en) * 1991-10-21 1993-04-28 Zeneca Limited Acridine-1,8-dione-derivatives as therapeutic agents
WO2000024741A2 (en) * 1998-10-28 2000-05-04 Abbott Laboratories Dihydropyridine compounds and their use as potassium channel openers

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0539154A1 (en) * 1991-10-21 1993-04-28 Zeneca Limited Acridine-1,8-dione-derivatives as therapeutic agents
WO2000024741A2 (en) * 1998-10-28 2000-05-04 Abbott Laboratories Dihydropyridine compounds and their use as potassium channel openers

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ACTA CRYSTALLOGR., SECT. C: CRYST. STRUCT. COMMUN. (2000), C56(3), 351-353 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; SIMSEK, RAHIME ET AL: "(.+-.)-9-(2-Bromophenyl)-7,7-dimethyl-1,3,4,5,6,7,8,9- octahydrofuro[3,4-b]quinoline-1,8-dione", XP002188093, retrieved from STN Database accession no. 132:301219 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; SKRASTINS, I. ET AL: "Cardiovascular activity of difuropyridines", XP002188094, retrieved from STN Database accession no. 118:51856 *
KHIM.-FARM. ZH. (1992), 26(5), 43-5 *
ROSE, U.: "Calcium modulators of the anellated dihydropyridine type. Synthesis and pharmacological action", ARZNEIM.-FORSCH. (1989), 39(11), 1393-8, XP002188092 *

Also Published As

Publication number Publication date
MXPA02010807A (en) 2003-04-14
EP1278746A2 (en) 2003-01-29
JP2004509840A (en) 2004-04-02
CA2407317A1 (en) 2001-11-08
WO2001083480A2 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
HK1047088A1 (en) Potassium channel openers
AU2001245437A1 (en) Lightweight methods and compositions for well treating
EP1572079A3 (en) Mammalian cdr mimetibodies, compositions, methods and uses
AUPQ527400A0 (en) Gate latch
WO2001009096A3 (en) Potassium channel openers
WO2002032871A3 (en) Compounds and methods for treating multidrug resistance
AU1747400A (en) Multiple-thickness gate oxide formed by oxygen implantation
AU2001237939A1 (en) Methods for treating glaucoma
WO2002062762A3 (en) Potassium channel openers
BG104999A (en) Cyclopentanone dihydropyridine compositions useful as potassium channel openers
AU2001275085A1 (en) Methods, compounds and compositions for treating gout
AU2002215333A1 (en) Compositions for release of radiosensitizers, and methods of making and using the same
AU2001251507A1 (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
IL135985A0 (en) Potassium channel openers
WO2000024741A3 (en) Dihydropyridine compounds and their use as potassium channel openers
AU2002241670A1 (en) Method for treating glaucoma IB
WO2001066544A3 (en) Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
AU2002239739A1 (en) Compositions, methods and kits relating to remodelin
WO2001083480A3 (en) Dihydropyridine compounds and methods of use
AU2001256998A1 (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
AU2002305700A1 (en) Composition and method for treating cells
AU2002361711A1 (en) METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832
WO2002043567A3 (en) A method of treating cancer
AU2002359362A1 (en) Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874
AU2001296075A1 (en) Composition for treating acne vulgaris and fabrication method

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP MX

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP MX

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

WWE Wipo information: entry into national phase

Ref document number: 2407317

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: PA/a/2002/010807

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2001934990

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001934990

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001934990

Country of ref document: EP